Equity Insider News Commentary ? Defense is no longer about physical walls; it is about the digital shield that protects them ...

According to MarketsandMarketstm, the Cloud OSS/BSS Market is projected to grow from USD 43.35 billion in 2025 and to reach USD 59.02 billion by 2032, at a Compound Annual Growth Rate (CAGR) of 4.2% ...

Microsoft 365 failed recently. The internet’s lack of a Plan B is the real issue, and we're expected to rely on cloud ...

Backed by Italy-based Fondazione Telethon ETS, Waskyra, for Wiskott-Aldrich syndrome, is the first gene therapy from a non-profit sponsor to win FDA approval. The FDA has approved the gene therapy ...

Gamida Cell has scored an expansion for Omisirge, with the FDA endorsing the stem-cell-based therapy to treat severe aplastic anemia (SAA). The approval, which comes more than two years after Omisirge ...

Following the news that US tech giant Amazon Web Services (AWS) experienced server trouble, affecting a wide range of apps including Lloyds Bank and its subsidiaries; Jonathan Vaughan Burleigh, ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of new research in Science Advances detailing the company's CRISPR-based ...

As cloud workloads continue to grow in complexity and scale, organizations face a persistent challenge: how to simultaneously deliver faster performance, lower costs, and meet sustainability ...

In conjunction with its announcement of Nova Forge, a platform for building customized variants of its Nova foundation models, Amazon Web Services Inc. today introduced four new artificial ...

A research team in Spain has built what it claims to be the world’s most efficient perovskite solar cell using MXenes or any other type of 2D-materials. The device relies on a Mxene interlayer that ...